There’s a growing body of evidence demonstrating technology-led digital transformations are overpromising and under-delivering returns on investment for
Marapharm Ventures, Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) (“Marapharm”, “Company”) announces that the Company has entered into a Definitive Agreement (the “Agreement”), to acquire certain operational assets and, potentially,